FY25 Appendix 4E & Annual Report
Filed with ASX · · 48 pages · English
This Appendix 4E should be read in conjunction with the Company’s Annual Report for the year ended 30 June 2025. Results for announcement to the market The FY2025 result includes a $3,892,596 gain on extinguishment arising from the DOCA. Dividends: There were no dividends paid, recommended or declared during the current or previous financial year. No final dividend is proposed and there is no divi
Genetic Technologies Limited on 6ix
Story so far
Earlier from Genetic Technologies
- Suspension from Official Quotation - Annual Listing Fees
- Quarterly Activities/Appendix 4C Cash Flow Report Sept 2025
- Quarterly Activities/Appendix 4C Cash Flow Report June 2025
- Quarterly Activities/Appendix 4C Cash Flow Report March 2025
- Update on Proposed Acquisition Strategy
Later from Genetic Technologies
All Genetic Technologies news releasesFollow Genetic Technologies into a list and get an email when it puts out news.
Follow Genetic Technologies